Medidata ($MDSO) has bolstered its books with two new deals. Accenture is tightening the ties between its R&D service offering and Medidata's Clinical Cloud and Rave EDC system. The deal expands a working relationship that dates back to 2002. Medidata also signed up CRO Biorasi as a partner. Biorasi is using Rave across its Phase I to IV clinical trials and is working toward adding ePRO and other tools. Release | More